George Martin

Mr. George K.
Martin is a Chairman at Ride Therapeutics, Inc., an Executive Chairman at Wavebreak Therapeutics Ltd., a Chairman at Serenus Biotherapeutics, Inc., a President & Chief Executive Officer at Elan Pharmaceuticals LLC, a Chief Executive Officer at Malin Life Sciences Holdings Ltd., a Chief Executive Officer at Radius Pharmaceuticals, Inc. and an Executive Chairman at Transition Bio, Inc. He is on the Board of Directors at Brandon Point Industries Unlimited Co. Mr. Martin was previously employed as an Independent Director by TriSalus Life Sciences, Inc., a President, Chief Executive Officer & Director by Radius Health, Inc., a Chief Executive Officer & Executive Director by Malin Corp.
Plc, a Chief Executive Officer & Non-Executive Director by Novan, Inc., an Independent Director by Viamet Pharmaceuticals Corp., a President, Chief Executive Officer & Director by Elan Corp.
Plc, a Chief Executive Officer by Elan Pharma Ltd., a Non-Executive Director by Immunocore Holdings Plc, and a Non-Executive Director by Kymab Ltd. He also served on the board at Questcor Pharmaceuticals, Inc., Poseida Therapeutics, Inc. and Viamet Pharmaceuticals, Inc. He received his undergraduate degree from Princeton University.